Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) T.ATE


Primary Symbol: ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by Doccoleon Jun 29, 2021 6:22pm
232 Views
Post# 33470585

Phase 3

Phase 3

It will be pushed again.  These guys plan to request FDA Q4 after AME.  Doubt that they will spin that out.  Considering Dan track record, this will not happen or occur 2022.

there is no pressure from Corp to turn this out.  They keep rewarding each other with shares only to sell with news.  

im more of a investor than trader.  I can see this is not worth the hold when there are better options to make money. I have a lot here and I continue to hold like many of you. 

finally- if you think we are headed in the right direction and everything is great, I would like to sell you some online Real estate on The Moon.  It takes time, but in comparison, this company should be valued way higher.  There has been a lot of failure here.  I respect the science team, not so much the management.

<< Previous
Bullboard Posts
Next >>